而NKT细胞扩增就复杂的多，本身NKT细胞占外周血T细胞不到1%，比例极低，需要CD1d+APC和α-GalCer刺激才能扩增。扩增效率远低于NK细胞，一般来说都不到10倍。

FDA Breakthrough Therapy Designation granted to lacutamab for relapsed or refractory Sézary syndrome New data, including lacutamab improved health-related quality of life data from TELLOMAK ...